Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: April 2019 (Specifically April 2, 2019)
Key Financial Metrics
This filing reports a specific capital raising event rather than periodic financial performance metrics.
- Capital Raised: Approximately $3,200,000 in gross proceeds.
- Transaction Type: Definitive agreement with certain institutional investors.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide clear values for these operational metrics.
Material Changes
The primary material change disclosed is the execution of a definitive agreement to raise approximately $3.2 million in gross proceeds from institutional investors on April 2, 2019.
Guidance, Outlook, and Risks
The filing incorporates a press release by reference but does not contain explicit management commentary, forward-looking guidance, risk factors, or contingencies within the text provided.
Investor Verification Checklist
- Verify the terms of the definitive agreement with institutional investors (e.g., security type, valuation, dilution impact) in the attached Exhibit 99.1 (Press Release).
- Confirm the use of proceeds for the $3.2 million capital raise.
- Review the company's most recent Form 20-F for baseline financial data (revenue, cash position, debt) as this 6-K does not contain them.